🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Role of Coenzyme Q10 in Chronic Kidney Disease

RecruitingPhase 4Ages 18 Years - anyAllTanta University
NCT05942027 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized placebo controlled double blind parallel clinical study will be conducted on 44 non-dialysis chronic kidney disease (CKD) patients (Stages 2-3b).Clinical Study Evaluating the Role of Coenzyme Q10 as Adjuvant Therapy to Angiotensin Converting Enzyme Inhibitor on Blood Pressure, Proteinuria and Bone Metabolism in Patients with Chronic Kidney Disease. Patients will be recruited from, Internal Medicine Department, Nephrology Unit, Alexandria Main University Hospital, Egypt. Patients with albumin-to-creatinine ratio ≥ 30 mg/g, with serum Potassium \< 5 mEq/L and newly diagnosed patients with hypertension. The study duration will be 6 months. The patients will be randomized using stratified random block method into two groups. Group 1: Control group Non-dialysis chronic kidney disease (CKD) patients (Stages 2-3b). Patients will be treated with ramipril 10 mg/day and a placebo

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years old. * Both sexes. * Patients matched in the duration of CKD. * Non-dialysis chronic kidney disease (CKD) patient with estimated glomerular filtration rate (GFR) 30-89 mL/min/1.73m2 (Stage 2-3b). * Patients with albumin-to-creatinine ratio ≥ 30 mg/g. * Patients with serum Potassium \< 5 mEq/L. * A newly diagnosed patients with hypertension. Exclusion criteria: * Patients with elevated level of potassium ≥ 5 mEq/L. * Patients with diabetes. * Patients with cancer. * Patients with heart disease. * Patients with hepato-biliary disease and other liver diseases. * Patients with kidney stones and urinary tract infection. * Patients with an overactive thyroid gland. * Patients with bleeding disorder. * History of drug allergy to ACEI or ARBs. * Pregnant and breastfeeding women. * Patients with blood pressure ≥180/110 or \<100/60. * Patients on alteplase, azothiopurine, everolimus, sirolimus, lithium, non-steroidal anti-inflammatory drugs (epifenac, tenoxicam, Celecoxib….), potassium retentive diuretics (amiloride, spironolactone), other ACEIs and ARBs will be excluded to avoid possible drug-drug interactions with ramipril. * Patients on omega-3 fatty acids; vitamins (especially A, C, E, K), Chemotherapy and oral anticoagulant (warfarin), cholestyramine, orlistate will be excluded to avoid possible drug interactions that could affect Coenzyme Q10
💊

What it tests

  • Placebo
  • Co-Enzyme Q10
📍

Where

1 site
Faculty of Pharmacy Tanta University
Tanta, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy